Semaglutide helps in diabetes management by mimicking the GLP-1 hormone, which enhances insulin secretion, reduces glucagon release, and slows gastric emptying, thereby lowering blood glucose levels and aiding in weight loss
While diabetic ketoacidosis (DKA) is not typically associated with GLP-1 RAs alone, patients using Ozempic with SGLT2 inhibitors or after significant insulin dose reductions should be alert to DKA symptoms and seek urgent care if these develop
The two medications work differently, and their dosing systems are not one-to-one, which is why beginning tirzepatide at 2.5 mg is common even for those previously on high semaglutide doses
Need exact units for a different vial size
Compared with lifestyle changes or older anti-obesity medications, our study in Obesity showed that GLP-1 receptor agonist regimens are superior for treating weight regain after bariatric surgery
Every step is guided